Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jerry Olson who wrote (2178)	5/7/1998 6:44:00 PM
From: Kenneth R Miller	Respond to of 9523

The chemical supplier is doing OK? LONDON, May 7 (Reuters) - Shares in chemicals group BTP Plc rose early on Thursday after newspaper reports sparked bid speculation around the company as well as highlighting its contract to supply ingredients for Pfizer'sPFE.N top-selling impotence drug Viagra. BTP shares gained 31p or 6.5 percent to 506 by 0732 GMT in trade of 140,650 shares. A report in the Times newspaper noted reports that Viagra had outsold Prozac after being on sale for less than two months, while the Daily Mail said there were market rumours of a bid for BTP at 550p. No-one at BTP could immediately be reached for comment.